• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tiracizine disposition in healthy volunteers with reference to the debrisoquine oxidation phenotype.

作者信息

Berndt A, Hoffmann C, Richter K, Oertel R, Vierkant A, Siegmund W

出版信息

Br J Clin Pharmacol. 1995 Sep;40(3):287-8. doi: 10.1111/j.1365-2125.1995.tb05788.x.

DOI:10.1111/j.1365-2125.1995.tb05788.x
PMID:8527295
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1365113/
Abstract
摘要

相似文献

1
Tiracizine disposition in healthy volunteers with reference to the debrisoquine oxidation phenotype.参考异喹胍氧化表型研究健康志愿者体内替拉西嗪的处置情况。
Br J Clin Pharmacol. 1995 Sep;40(3):287-8. doi: 10.1111/j.1365-2125.1995.tb05788.x.
2
Day-night variations in the renal excretion of the antiarrhythmic agent tiracizine and its metabolites.
Chronobiol Int. 1995 Apr;12(2):135-40. doi: 10.3109/07420529509064508.
3
Dose dependent tiracizine disposition in healthy volunteers: serum and urine kinetics and dose related ECG-changes.健康志愿者中替拉西嗪的剂量依赖性处置：血清和尿液动力学及剂量相关的心电图变化
Eur J Drug Metab Pharmacokinet. 1994 Oct-Dec;19(4):359-68. doi: 10.1007/BF03188863.
4
[Relative bioavailability of the antiarrhythmia agent, tiracizine and its metabolites].
Arzneimittelforschung. 1995 Mar;45(3):250-3.
5
Pharmacokinetics of the antiarrhythmic agent tiracizine: steady state kinetics in comparison with single-dose kinetics.
Biopharm Drug Dispos. 1995 Jul;16(5):427-41. doi: 10.1002/bdd.2510160507.
6
Lack of relationship between glibenclamide metabolism and debrisoquine or mephenytoin hydroxylation phenotypes.格列本脲代谢与异喹胍或美芬妥因羟化表型之间缺乏相关性。
Br J Clin Pharmacol. 1990 Sep;30(3):476-80. doi: 10.1111/j.1365-2125.1990.tb03800.x.
7
Debrisoquine oxidation phenotype during neuroleptic monotherapy.抗精神病药物单一疗法期间的异喹胍氧化表型
Eur J Clin Pharmacol. 1991;41(5):467-70. doi: 10.1007/BF00626371.
8
Determination of debrisoquine oxidation phenotype in healthy volunteers during phase I trials.在I期试验期间对健康志愿者进行异喹胍氧化表型的测定。
Therapie. 1996 Mar-Apr;51(2):191-2.
9
Comparative effects of the diastereoisomers, quinine and quinidine in producing phenocopy debrisoquine poor metabolisers (PMs) in healthy volunteers.在健康志愿者中，奎宁和奎尼丁这两种非对映异构体产生苯妥英钠异喹胍慢代谢者（PMs）的比较效应。
Chirality. 1991;3(1):14-8. doi: 10.1002/chir.530030104.
10
The relationship between debrisoquine oxidation phenotype and the pharmacokinetics and pharmacodynamics of propranolol.异喹胍氧化表型与普萘洛尔的药代动力学和药效学之间的关系。
Br J Clin Pharmacol. 1984 Jun;17(6):679-85. doi: 10.1111/j.1365-2125.1984.tb02403.x.

本文引用的文献

1
Dose dependent tiracizine disposition in healthy volunteers: serum and urine kinetics and dose related ECG-changes.健康志愿者中替拉西嗪的剂量依赖性处置：血清和尿液动力学及剂量相关的心电图变化
Eur J Drug Metab Pharmacokinet. 1994 Oct-Dec;19(4):359-68. doi: 10.1007/BF03188863.
2
N-acetylation and debrisoquine type oxidation polymorphism in Caucasians--with reference to age and sex.
Int J Clin Pharmacol Ther Toxicol. 1990 Dec;28(12):504-9.
3
[Electrophysiological anti-arrhythmia effects of tiracizine in ventricular tachycardia].[替拉西嗪对室性心动过速的电生理抗心律失常作用]
Z Gesamte Inn Med. 1991 Dec;46(17):635-41.